Phototherapy, photochemotherapy, and photodynamic therapy: Unapproved uses or indications

Clinics in Dermatology

Volumn 18, Issue 1, 2000, Pages 77-86

  Ledo, Elena ^a   Ledo, Antonio ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN; PSORALEN;

ALOPECIA AREATA; ATOPIC DERMATITIS; HUMAN; MYCOSIS FUNGOIDES; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PRURIGO; PUVA; REVIEW; TREATMENT INDICATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; DERMATOLOGIC AGENTS; DRUG APPROVAL; HUMANS; PUVA THERAPY; SKIN DISEASES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0033980496     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00096-6     Document Type: Review

References (115)

1. Goeckermann W.H. The treatment of psoriasis. Northwest Med. 23:1925;229-231.
2. Ledo A., Gomez Orbaneja J. Tratamiento de la alopecia areata por el Ammi majus. Actas Dermosifilio. 46:1955;321-324.
3. Parrish J.A., Fitzpatrick T.B., Tanenbaun L., et al. Photochemotherapy of psoriasis with oral methoxalen and long-wave ultraviolet light. N Engl J Med. 291:1974;1207-1211.
4. Drake L.A. Guidelines of care for phototherapy and photochemotherapy. J Am Acad Dermatol. 31:1994;643-648.
5. Honig B., Morison W.L., Karp D. Photochemotherapy beyond psoriasis. J Am Acad Dermatol. 31:1994;775-790.
6. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 124:1988;869-871.
7. Lauharanta J. Phochemotherapy. Clin Dermatol. 15:1997;769-780.
8. Morison W.L., Waughman R.D., Day R.M. Consensus workshops on the toxic effects of long-term PUVA therapy. Arch Dermatol. 134:1998;595-598.
9. Moreau A., Leroy D. Les nouvelles phototherapies. Ann Dermatol Venereol. 123:1996;510-518.
10. Berker D.A.R., Sakuntabhai A., Diffey B.L., et al. Comparison of psoralen-UVB and psoralen-UVA photochemotherapy in the treatment of psoriasis. J Am Acad Dermatol. 36:1997;577-581.
11. Vedaldi D., Caffieri S., Frank S., et al. Sulphur and selenium analogues of psoralen as novel potential photochemotherapeutic agents. Farmaco. 50:1995;527-536.
12. Jacobs A.E., Piette J. 1-Thiomethoxalen and 1-thiopsoralen Synthesis, photobiological properties and site-specific reaction of thiopsoralens with DNA. J Med Chem. 38:1995;869-874.
13. Aubin, et al. Effects of a new psoralen, 5-geranoxypsoralen, plus PUVA radiation on murine ATPase-positive Langerhans cells. J Dermatol Sci. 7:1994;176-184.
14. Gia O., Anselmo A., Conconi M., et al. Synthesis and photobiological activity. J Med Chem. 39:1996;4489-4496.
15. Lassus A., Kianto U., Johansson E., et al. PUVA treatment for alopecia areata. Dermatologica. 161:1980;298-304.
16. Morison W.L., et al. Oral psoralen photochemotherapy of atopic eczema. Br J Dermatol. 98:1978;25-30.
17. Atherton D.J., Carabott F., Glover M.T., et al. The role of psoralen photochemotherapy (PUVA) in the treatment of severe atopic eczema in adolescents. Br J Dermatol. 118:1988;791-795.
18. Dahl K.B., Reymann F. Photochemotherapy in erythrodermic seborrheic dermatitis. Arch Dermatol. 113:1977;1295-1296.
19. Tegner E. Seborrhoeic dermatitis of the face induced by PUVA treatment. Acta Derm Venereol (Stockh). 63:1983;335-339.
20. Morison W.L., Parrish J.A., Fitzpatrick T.B. Oral methoxsalen photochemotherapy of recalcitrant dermatoses of the palms and soles. Br J Dermatol. 99:1978;297-302.
21. Mobacken H., Rosen K., Swanbeck G. Oral psoralen photochemotherapy (PUVA) of hyperkeratotic dermatitis of the palms. Br J Dermatol. 109:1983;205-208.
22. Bruynzeel D.P., Boonk W.J., van Ketel W.G. Oral psoralen photochemotherapy of allergic contact dermatitis of the hands. Derm Berul Umwelt. 30:1982;16-20.
23. Volc-Platzer B., Hönigsmann H., Hinterberg W., et al. Photochemotherapy improves chronic cutaneous graft-versus-host disease. J Am Acad Dermatol. 23:1990;220-228.
24. Jampel R.M., Farmer E.R., Volgesang G.B. PUVA therapy for chronic cutaneous graft-vs-host disease. Arch Dermatol. 127:1991;1673-1678.
25. Hymes S.R., Morison W.L., Farmer E.R., et al. Methoxsalen and ultraviolet-A radiation in treatment of cutaneous graft-vs-host reaction. J Am Acad Dermatol. 12:1985;30-37.
26. Zmudzka B.Z., Miller S.A., Jaconbos M.E., et al. Medical UV exposures and HIV activation. Photochem Photobiol. 64:1996;246-253.
27. Morison W.L. PUVA therapy is preferable to UVB phototherapy in the management of HIV-associated dermatoses. Photochem Photobiol. 64:1996;267-268.
28. Zmudzka B.Z., Beer J.Z. Ultraviolet therapy and patients with HIV infection. Arch Dermatol. 134:1998;1025-1026.
29. Breuer-McHam J., et al. Alterations on HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy. J Am Acad Dermatol. 40:1999;48-60.
30. Iwasuki K., Tsugiki M., Yoshizawa N., et al. The effect of phototherapies on cutaneous lesions of histiocytosis X in the elderly. Cancer. 57:1986;1931-1936.
31. Ortonne J.P., Thivolet J., Sannwald C. Oral photochemotherapy in the treatment of lichen planus (LP). Br J Dermatol. 99:1978;77-88.
32. Helander I., Jansen C.T., Meurman L. Long-term efficacy of PUVA treatment in lichen planus Comparison of oral and external methoxsalen regimens. Photodermatol Photoimmunol Photomed. 4:1987;265-268.
33. Randle H.W., Sander H.M. Treatment of generalized lichen nitidus with PUVA. Int J Dermatol. 25:1986;330-331.
34. Gilchrest B.A., Parrish J.A., Tanenbaum L., et al. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer. 38:1976;683-689.
35. Roenigk H.H. Photochemotherapy for mycosis fungoides. Arch Dermatol. 113:1977;1047-1051.
36. Abel E.A., Deneau D.G., Faber E.M., et al. PUVA treatment of erythrodermic and plaque-type mycosis fungoides. J Am Acad Dermatol. 4:1981;423-429.
37. Powell F.C., Spiegel G.T., Muller S.A. Treatment of parapsoriasis and mycosis fungoides The role of psoralen and long-wave ultraviolet light A (PUVA). Mayo Clin Proc. 59:1984;538-546.
38. Thomsen K., Hammar H., Molin L., et al. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. Acta Derm Venereol (Stockh). 9:1989;536-538.
39. 2). Cancer. 32:1973;18-30.
40. Prince N.M., Constantine V.S., Hoppe R.T., et al. Topical mechlorethamine therapy for mycosis fungoides. Br J Dermatol. 97:1977;547-550.
41. a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol 1990;95(Suppl):198S-205S.
42. Mostow E.N., Neckel S.L., Oberhelman L., et al. Complete remission in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alpha and PUVA. Arch Dermatol. 129:1993;747-752.
43. Kaye F.J., Bunn P.A., Steinber S.M., et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with typical therapy in te nicial treatment of mycosis fungoides. N Engl J Med. 321:1989;1784-1790.
44. Morison W.L., Stern R.S. Polymorphous light eruption A common reaction uncommonly recognized. Acta Derm Venereol (Stockh). 62:1982;237-240.
45. Frain-Bell W., Dickson A., Herd J., et al. The action spectrum in polymorphic light eruption. Br J Dermatol. 89:1973;243-249.
46. Holzle E., Plewig G., Hofmann C., et al. Polymorphous light eruption. J Am Acad Dermatol. 7:1982;111-125.
47. Jasen C.T., Karvonen J., Malmiharju T. PUVA therapy for polymorphous light eruptions Comparison of systemic methoxsalen and topical trioxsalen regimens and evaluation of local protective mechanism. Acta Derm Venereol (Stockh). 62:1982;317-320.
48. Molin L., Volden G. Treatment of polymorphous light eruption with PUVA and prednisolone. Photodermatol Photoimmunol Photomed. 4:1987;107-108.
49. Ravits M., Armstrong R.B., Haber L.C. Solar urticaria. Arch Dermatol. 118:1982;228-231.
50. Parrish J.A., Jaenicke K.F., Morison W.L., et al. Solar urticaria Treatment with PUVA mediator inhibitors. Br J Dermatol. 106:1982;575-580.
51. Bernhard J.D., Jaencke K., Momtaz T.K., et al. Ultraviolet-A phototherapy in the prophylaxis of solar urticaria. J Am Acad Dermatol. 10:1984;29-33.
52. Roelandts R. Chronic actinic dermatitis. J Am Acad Dermatol. 28:1993;240-249.
53. Yokel B.K., Hood A.F., Morison W.L. Management of chronic photosensitive eczema. Arch Dermatol. 126:1990;1283-1285.
54. LeVine M.J. Phototherapy of pityriasis lichenoides. Arch Dermatol. 119:1983;378-380.
55. Boelen R.E., Faber W.R., Lambers J.C.C.A., et al. Long-term follow-up of photochemotherapy in pityriasis lichenoides. Acta Dermtol. 62:1982;422-444.
56. Sherertz E.F., Jorizzo J.L., White W.L., et al. Papular dermatitis in adults Subacute prurigo, American style? J Am Acad Dermatol. 24:1991;697-702.
57. Mizuno N., Uematsu S., Ohno M. Methoxsalen and irradiation Treatment for pustulosis palmaris et plantaris. Arch Dermatol. 112:1976;883-884.
58. Murray D., Corbett M.F.A.P. A controlled trial of photochemotherapy for persistent palmoplantar pustulosis. Br J Dermatol. 102:1980;659-665.
59. Wilkinson J.D., Ralfs I.G., Harper J.I., et al. Topical methoxsalen photochemotherapy in the treatment of palmoplantar pustulosis and psoriasis. Acta Derm Venereol Suppl. 59:1979;193-198. (Stockh).
60. Parrish J.A., Fitzpatrick T.B., Shea C., et al. Photochemotherapy of vitiligo. Arch Dermatol. 112:1976;1531-1534.
61. Wennerstein G., Hagermark O. Outdoor and office photochemotherapy of vitiligo A comparison. Photodermatol Photoimmunol Photomed. 1:1984;91-93.
62. Kenny J.A. Vitiligo treated by psoralens. Arch Dermatol. 103:1971;474-480.
63. Skouge J.W., Morison W.L., Diwan R.V., et al. Autografting and PUVA. J Dermatol Surg Oncol. 18:1992;357-360.
64. Christophers E., et al. PUVA treatment of urticatia pigmentosa. Br J Dermatol. 98:1978;701-702.
65. Steinman H.K., Greaves M.W. Aquagenic pruritus. J Am Acad Dermatol. 13:1985;91-96.
66. Du H., Menage P., Norris P.G., et al. The efficacy of psoralen photochemotherapy in the treatment of aquagenic pruritus. Br J Dermatol. 129:1993;163-165.
67. Kalimo K., Lammintausta K., Viander M., et al. PUVA treatment of dermatitis herpetiformis. Photodermatol Photoimmunol Photomed. 3:1986;54-55.
68. Ros A.M. PUVA therapy for erythropoietic protoporhyria. Photodermatol Photoimmunol Photomed. 5:1988;148-149.
69. Ghetti P, et al. A case of erythrokeratodermia progressiva symmetrica: PUVA treatment. Int Cong Dermatol Abstract Book 1987;78.
70. Van den Hoogenband H.M., van den Berg W.H.H.W., van Diggelen M.W. PUVA therapy in the treatment of skin lesions of the hypereosinophilic syndrome. Arch Dermatol. 121:1985;450.
71. Morison W.L., Anhalt G.J. Therapy with oral psoralen plus UVA for erythema multiforme. Arch Dermatol. 133:1997;1465-1466.
72. Hindson T.C., Spiro J.G., Cochrane H. PUVA therapy of diffuse granuloma annulare. Clin Exp Dermatol. 13:1988;26-27.
73. Kerker B.J., Huang C.P., Morison W.L. Photochemotherapy of generalized granuloma annulare. Arch Dermatol. 126:1990;359-361.
74. Lang P.G. Keratosis lichenoides chronica. Arch Dermatol. 117:1981;105-108.
75. Nagata T. Netherton’s syndrome which responded to photochemotherapy. Dermatologica. 161:1980;51-56.
76. Wakeel R.A., Keefe M., Chapman R.S. Papuloerythroderma. Arch Dermatol. 127:1991;96-98.
77. Leenutaphong V., Jiamton S. UVB phototherapy for pityriasis rosea A bilateral comparison study. J Am Acad Dermatol. 33:1995;996-999.
78. Robertson K.E., Muller B.A. Uremic pruritus. Am J Health Syst Pharm. 53:1996;2159-2170.
79. Morison W.L., Nesbit J.A. Oral psoralen photochemotherapy for pruritus associated with polycythemia vera and myelofibrosis. Am J Hematol. 42:1993;409-410.
80. Farr P.M., Ive F.A. PUVA treatment of scleromyxoedema. Br J Dermatol. 110:1984;347-350.
81. Kerscher M., Volkenant M., Gruss C., et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol. 38:1998;21-26.
82. Paul B.S., Arndt K.A. Response of transient acantholytic dermatitis to photochemotherapy. Arch Dermatol. 120:1984;121-122.
83. Orton D.I., George S.A. Subcorneal pustular dermatosis responsive to narrowband (TL01) UVB phototherapy. Br J Dermatol. 137:1997;149-150.
84. Berne B., Fischer T., Michaëlsson G., et al. Long-term safety of trioxsalen bath PUVA treatment An 8-year follow-up study of 149 psoriasis patients. Photodermatology. 1:1984;18-22.
85. Goméz M.I., Azaña J.M., Arranz I., et al. Plasma levels of 8-MOP after bath-PUVA for psoriasis Relationship to disease severity. Br J Dermatol. 133:1995;37-40.
86. Gomez M.I., Perez B., Harto A., et al. 8-MOP bath-PUVA in the treatment of psoriasis Clinical result in 42 patients. J Dermatol Treat. 7:1996;11-14.
87. Turjanmmaa K., Salo H., Reunala T. Comparison of triosoralen bath and oral 8-methosalen PUVA. Acta Derm Venereol. 65:1985;86-88.
88. Lowe N.J., Weingarten D., Bourget T., et al. PUVA therapy for psoriasis Comparison of oral and bath-water delivery of 8-MOP. J Am Acad Dermatol. 14:1986;754-760.
89. Lindelöf B., Sigurgeirsson B., Tegner E., et al. Comparison of the carcinogenic potential of trioxsoralen bath PUVA and oral methoxsalen PUVA. Arch Dermatol. 128:1992;1341-1344.
90. Neuman N.J., et al. Evaluation PUVA bath phototoxicity. Fifth Congress of the European Acad Dermatol, Lisbon. 7:1966;S117.
91. Gonzalez S., Pathak M.A. Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation erythema and skin photosensitization by polypodium leucotomos. Photodermtol Photoinmunol Photomed. 12:1996;45-46.
92. Gonzalez S., et al. Development of cutaneous tolerance to ultraviolet B during ultraviolet B phototherapy for psoriasis. Photodermatol Photoinmunol Photomed. 12:1996;73-78.
93. Ledo E, Heras ME, Rocamora A, et al. Reducción de las dosis acumulativas en el PUVA tópico con un extracto de Polypodium leucotomos. Med Cut Iber Lat Am (in press).
94. Luftl M., Degitz K., Plewig G., et al. Psoralen bath plus UV-A therapy. Arch Dermatol. 133:1997;1597-1603.
95. Schempp CM, y col. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol 1997;36:733-7.
96. Väatäinen N., Hannuksela M., Karvonen J. Trioxsalen baths plus UV-A in the treatment of lichen planus and urticaria pigmentosa. Clin Exp Dermatol. 6:1981;133-138.
97. Fischer T, Skoghn M. Treatment of parapsoriasis en plaque, mycosis fungoides, and Sézary’s syndrome with trioxsalen baths followed by ultraviolet light. Acta Derm Venereol 1979(Stockh);59:171-3.
98. Väatäinen N., Hannuksela M., Karvonen J. Local photochemotherapy in nodular prurigo. Acta Derm Venereol Suppl (Stockh). 59:1979;544-547.
99. Volc-Platzer B., Hönigsmann H., Hinterberg W., et al. Photochemotherapy improves chronic cutaneous graft-versus-host disease. J Am Acad Dermatol. 23:1990;220-228.
100. Kerscher M., Volkenandt M., Meurer M., et al. Treatment of localised scleroderma with PUVA-bath photochemotherapy. Lancet. 343:1994;1233.
101. Kerscher M, Meurer M, Sander C, et al. PUVA-bath-photochemotherapy for scleroderma (abstract). J Invest Dermatol 1995;105:504.
102. Streit V., Wiedow O., Christophers E. Innovative Balneotherapie mit reduzierten Badevolumina Folienbader. Hautartz. 45:1994;140-144.
103. Hudson. Granuloma faciale Treatment with topical psoralen and UVA. J Am Acad Dermatol. 8:1983;559.
104. El Din Selim M.M., et al. Pustular eruption of pregnancy treated with locally administered PUVA. Arch Dermatol. 126:1990;443.
105. Oseroff AR. Photodynamic therapy. 57th Annual Meeting, AAD, New Orleans, 1999.
106. Jones C.M., Mang T., Cooper M., et al. Photodynamic therapy in the treatment of Bowen’s disease. J Am Acad Dermatol. 27:1992;979-982.
107. Robinson P.J., Carruth J.A.S., Fairris G.M. Photodynamic therapy A better treatment for. . despread Bowen’s disease. Br J Dermatol. 119:1998;59-61.
108. Stables GL, Stringer MR, Ash DV. The treatment of erythroplasia of Queyrat by topical aminolevulinic acid photodynamic therapy. Br J Dermatol 1995;133(Suppl 45):30.
109. Stehbder I.M., Wulf H.C. Photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic cheilitis. Br J Dermatol. 135:1996;454-456.
110. Wolf P., Fink-Puches R., Cerroni L., et al. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol. 31:1994;678-680.
111. Ammann R., Hunziker T. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol. 33:1995;541.
112. Schweitzer V.G., Visscher D. Photodynamic therapy for treatment of AIDS-related oral Kaposi’s sarcoma. Otolaryngol Head Neck Surg. 102:1990;639-694.
113. Pres H., Meffert H., Sonnichson M. Photodynamic therapy of psoriasis palmaris et plantaris using topically applied hematoporphyrin derivative and visible light. Dermatol Monatsschr. 175:1989;745-750.
114. Boehncke W.H., Sterry W., Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet. 343:1994;801.
115. Fritsch C., Kalka K., Lehmann P., et al. Fluorescence detection of 8-aminolevulinic acid induced porphyrins (photodynamic diagnosis) in dermatology. Z Hautkr H G. 72:1997;570-576.